CCL Products (India) Limited (CCL) — Announcement(2 announcements)

· NSE 🔴 High Importance Neutral
1 Announcement 🔴 High Importance Neutral 📄 PDF
📢 Key Event
Company grants stock options and restructures senior management
🔄 What Changed
148473 options vested, 161850 new options granted
💡 Investor Takeaway
Shareholders should note the dilutive impact of new stock options and management restructuring.

CCL Products (India) announced vesting of 148,473 stock options and grant of 161,850 new options under its 2022 Employee Stock Option Scheme, alongside reclassification of senior management roles. The filing details compliance with SEBI regulations and outlines option terms including Rs.2 exercise price and two-year exercise window.

2 Announcement Neutral 📄 PDF
📢 Key Event
Committee approves vesting of 1,48,473 options and grant of 1,61,850 new options under 2022 ESOP scheme
🔄 What Changed
1,48,473 options vested; 1,61,850 options newly granted; 6,475 options lapsed; senior management reclassification approved
🔮 What's Next
Options exercisable within 2 years from vesting date
💡 Investor Takeaway
Shareholders see potential dilution from new option grants but no immediate cash impact or earnings effect.

CCL Products (India) Limited announced on May 7, 2026 that its Nomination and Remuneration Committee approved the vesting of 1,48,473 stock options and granted 1,61,850 new options under the 2022 Employee Stock Option Scheme, alongside reclassifying senior management roles including CEO Praveen Jaipuriar and CFO Chaitanya Agasthyaraju. The options carry a Rs.2 face value exercise price, vest upon performance targets, and remain exercisable for two years post-vesting, with 6,475 options lapsed due to employee resignations.

About CCL Products (India) Limited (CCL)

Fast Moving Consumer Goods · Agricultural Food & other Products · Listed on NSE

Market Cap: ₹14,905.72 Cr P/E: 54.3

View full CCL stock details →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.